DIVITA CHARLES III

Track

Insider profile

Performance

Overall performance
1.9
Performance over holding periods
1.9
30 days 90 days 120 days
Average return -10% 8.2% 15.1%
Success rate 36% 68% 82%
Transactions
8 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
DIVITA CHARLES III's trades of Teladoc Health Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-12 2026-06-11
S Sale
524 -30.1%
159.15
US$4,918,607 		524 -30.1% 159.15 US$4,918,607
2026-06-12 2026-06-11
S Sale
7,649 +33.9%
237.28
US$2,132,439 		7,649 +33.9% 237.28 US$2,132,439
2026-06-11 2026-06-11
PrS Proposed sale
68,236
450.14
US$2,458,383 		68,236 450.14 US$2,458,383
2026-06-03 2026-06-02
S Sale
19,132 -4.7%
7.63
US$145,920 		19,132 -4.7% 7.63 US$145,920
2026-06-02 2026-06-02
PrS Proposed sale
19,132
7.63
US$145,920 		19,132 7.63 US$145,920
2026-03-12 2026-03-11
S Sale
27,731 -7.1%
5.49
US$152,243 		27,731 -7.1% 5.49 US$152,243
2026-03-12 2026-03-11
S Sale
27,731 -7.1%
5.49
US$152,243 		27,731 -7.1% 5.49 US$152,243
2026-03-11 2026-03-11
PrS Proposed sale
27,731
5.49
US$152,252 		27,731 5.49 US$152,252
2026-03-03 2026-03-02
S Sale
50,145 -13.3%
5.12
US$256,592 		50,145 -13.3% 5.12 US$256,592
2026-03-02 2026-03-02
PrS Proposed sale
50,145
5.12
US$256,577 		50,145 5.12 US$256,577
2025-12-11 2025-12-11
PrS Proposed sale
17,138
7.63
US$130,837 		17,138 7.63 US$130,837
2025-12-11 2025-12-11
S Sale
17,138 -7.9%
7.63
US$130,837 		17,138 -7.9% 7.63 US$130,837
2025-09-11 2025-09-11
PrS Proposed sale
16,787
7.59
US$127,435 		16,787 7.59 US$127,435
2025-09-11 2025-09-11
S Sale
16,787 -8.6%
7.59
US$127,435 		16,787 -8.6% 7.59 US$127,435